https://www.selleckchem.com/pr....oducts/meclofenamate
There is limited understanding of the characteristics of coronavirus disease 2019 (COVID-19) patients requiring hospitalization in Japan. This study included 2638 cases enrolled from 227 health care facilities that participated in the COVID-19 Registry Japan (COVIREGI-JP). The inclusion criteria for enrollment of a case in COVIREGI-JP are both (1) a positive SARS-CoV-2 test and (2) inpatient treatment at a health care facility. The median age of hospitalized patients with COVID-19 was 56 years (interquartile range [IQR] 40-
Gefällt mir
Kommentar
Teilen
